Literature DB >> 7871059

Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.

M E Benwell1, D J Balfour, H M Lucchi.   

Abstract

The influence of tetrodotoxin (TTX) and calcium on the increase of extracellular dopamine (DA) levels in the nucleus accumbens (NAcc), evoked by the systemic administration of nicotine, cocaine and d-amphetamine, have been studied in conscious, freely moving rats using in vivo microdialysis. TTX (10(-6) M), administered via the dialysis probe, completely abolished (P < 0.01) the elevations in extracellular DA, DOPAC and HVA seen following nicotine (0.4 mg/kg SC). The removal of calcium with the inclusion of diaminoethanetetraacetic acid (EDTA 10(-4) M) in the Ringer solution was also associated with inhibition (P < 0.01) of the nicotine-induced changes in these parameters. The systemic administration of cocaine (15 mg/kg IP) and d-amphetamine (0.5 mg/kg SC) caused elevations in extracellular DA (P < 0.01) accompanied by significant decreases (P < 0.01) in HVA levels. DOPAC levels were also significantly (P < 0.01) lowered by d-amphetamine treatment. The presence of TTX and removal of calcium with addition of EDTA completely abolished the changes in NAcc DA and HVA induced by cocaine. TTX had no influence on the d-amphetamine evoked responses in NAcc DA. However, the metabolites, which were markedly reduced by the TTX, were not further decreased by the systemic administration of d-amphetamine. NAcc DA was significantly (P < 0.01) raised following d-amphetamine in the absence of calcium and presence of EDTA. However, this was significantly (P < 0.01) attenuated in comparison to that seen in the presence of calcium. The results support the conclusion that, at the dose tested, nicotine evokes increases in extracellular NAcc DA levels by calcium and impulse-dependent mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871059     DOI: 10.1007/bf02244896

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.

Authors:  R E Heikkila; H Orlansky; G Cohen
Journal:  Biochem Pharmacol       Date:  1975-04-15       Impact factor: 5.858

2.  Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.

Authors:  P W Kalivas; P Duffy
Journal:  Synapse       Date:  1990       Impact factor: 2.562

3.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

Review 4.  A psychomotor stimulant theory of addiction.

Authors:  R A Wise; M A Bozarth
Journal:  Psychol Rev       Date:  1987-10       Impact factor: 8.934

5.  Pathophysiology of pH and Ca2+ in bloodstream and brain.

Authors:  G G Somjen; B W Allen; M Balestrino; P G Aitken
Journal:  Can J Physiol Pharmacol       Date:  1987-05       Impact factor: 2.273

6.  Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens.

Authors:  G Damsma; J Day; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1989-09-22       Impact factor: 4.432

7.  Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat.

Authors:  G Singer; M Wallace; R Hall
Journal:  Pharmacol Biochem Behav       Date:  1982-09       Impact factor: 3.533

8.  Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine.

Authors:  G Mereu; K W Yoon; V Boi; G L Gessa; L Naes; T C Westfall
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

9.  Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum.

Authors:  S Izenwasser; H M Jacocks; J G Rosenberger; B M Cox
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

10.  Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats.

Authors:  M F O'Neill; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  8 in total

1.  Amphetamine stimulates movement through thalamocortical glutamate release.

Authors:  Omar S Mabrouk; Daniel Z Semaan; Sarah Mikelman; Margaret E Gnegy; Robert T Kennedy
Journal:  J Neurochem       Date:  2013-08-19       Impact factor: 5.372

2.  Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.

Authors:  M E Benwell; D J Balfour; C E Birrell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

Review 3.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

4.  Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Authors:  Alexander R Kosowski; Gvido Cebers; Aleta Cebere; Ann-Charlott Swanhagen; Sture Liljequist
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

Review 5.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

6.  Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.

Authors:  Dan P Covey; Kendra D Bunner; Douglas R Schuweiler; Joseph F Cheer; Paul A Garris
Journal:  Eur J Neurosci       Date:  2016-05-11       Impact factor: 3.386

7.  Essential role of NMDA receptor channel ε4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine.

Authors:  Yoko Hagino; Shinya Kasai; Wenhua Han; Hideko Yamamoto; Toshitaka Nabeshima; Masayoshi Mishina; Kazutaka Ikeda
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.

Authors:  Dan P Covey; Steven A Juliano; Paul A Garris
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.